K2M Group (KTWO) Sees Unusually-High Trading Volume

K2M Group Holdings Inc (NASDAQ:KTWO) saw strong trading volume on Thursday . 13,548,967 shares changed hands during trading, an increase of 2,034% from the previous session’s volume of 634,978 shares.The stock last traded at $27.50 and had previously closed at $26.94.

Several equities research analysts have recently commented on the company. ValuEngine upgraded K2M Group from a “hold” rating to a “buy” rating in a research note on Thursday, August 30th. Oppenheimer cut K2M Group from an “outperform” rating to a “hold” rating in a research report on Friday, August 31st. BidaskClub cut K2M Group from a “buy” rating to a “hold” rating in a research report on Thursday. JMP Securities cut K2M Group from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 30th. Finally, Needham & Company LLC cut K2M Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 30th. One analyst has rated the stock with a sell rating, eight have issued a hold rating, one has given a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $26.17.

The stock has a market capitalization of $1.17 billion, a PE ratio of -31.61 and a beta of 1.43. The company has a quick ratio of 2.13, a current ratio of 3.48 and a debt-to-equity ratio of 0.51.

K2M Group (NASDAQ:KTWO) last released its quarterly earnings data on Thursday, November 8th. The medical device company reported ($0.29) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.17) by ($0.12). K2M Group had a negative return on equity of 16.27% and a negative net margin of 14.49%. As a group, analysts expect that K2M Group Holdings Inc will post -0.77 earnings per share for the current fiscal year.

In other K2M Group news, CFO Gregory S. Cole sold 82,304 shares of the company’s stock in a transaction on Thursday, August 30th. The stock was sold at an average price of $27.40, for a total value of $2,255,129.60. Following the sale, the chief financial officer now owns 147,963 shares of the company’s stock, valued at $4,054,186.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Gregory S. Cole sold 1,480 shares of the company’s stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $20.08, for a total value of $29,718.40. Following the completion of the sale, the chief financial officer now directly owns 65,659 shares in the company, valued at approximately $1,318,432.72. The disclosure for this sale can be found here. Insiders sold 84,479 shares of company stock worth $2,298,880 in the last three months. 6.00% of the stock is owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of the business. Rhumbline Advisers grew its holdings in K2M Group by 7.4% in the second quarter. Rhumbline Advisers now owns 39,058 shares of the medical device company’s stock valued at $879,000 after purchasing an additional 2,682 shares during the last quarter. Sei Investments Co. grew its holdings in K2M Group by 4.3% in the second quarter. Sei Investments Co. now owns 96,897 shares of the medical device company’s stock valued at $2,181,000 after purchasing an additional 4,001 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in K2M Group in the third quarter valued at $115,000. Westwood Management Corp IL grew its holdings in K2M Group by 13.5% in the second quarter. Westwood Management Corp IL now owns 42,000 shares of the medical device company’s stock valued at $945,000 after purchasing an additional 5,000 shares during the last quarter. Finally, Waddell & Reed Financial Inc. grew its holdings in K2M Group by 0.3% in the second quarter. Waddell & Reed Financial Inc. now owns 2,220,769 shares of the medical device company’s stock valued at $49,967,000 after purchasing an additional 6,790 shares during the last quarter.

COPYRIGHT VIOLATION NOTICE: “K2M Group (KTWO) Sees Unusually-High Trading Volume” was posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.baseballdailydigest.com/2018/11/10/k2m-group-ktwo-sees-unusually-high-trading-volume.html.

About K2M Group (NASDAQ:KTWO)

K2M Group Holdings, Inc, a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.

Recommended Story: Call Option

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply